These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30098419)

  • 21. Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer.
    Duijvesz D; Versluis CY; van der Fels CA; Vredenbregt-van den Berg MS; Leivo J; Peltola MT; Bangma CH; Pettersson KS; Jenster G
    Int J Cancer; 2015 Dec; 137(12):2869-78. PubMed ID: 26139298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy.
    Lawrence MG; Obinata D; Sandhu S; Selth LA; Wong SQ; Porter LH; Lister N; Pook D; Pezaro CJ; Goode DL; Rebello RJ; Clark AK; Papargiris M; Van Gramberg J; Hanson AR; Banks P; Wang H; Niranjan B; Keerthikumar S; Hedwards S; Huglo A; Yang R; Henzler C; Li Y; Lopez-Campos F; Castro E; Toivanen R; Azad A; Bolton D; Goad J; Grummet J; Harewood L; Kourambas J; Lawrentschuk N; Moon D; Murphy DG; Sengupta S; Snow R; Thorne H; Mitchell C; Pedersen J; Clouston D; Norden S; Ryan A; Dehm SM; Tilley WD; Pearson RB; Hannan RD; Frydenberg M; Furic L; Taylor RA; Risbridger GP
    Eur Urol; 2018 Nov; 74(5):562-572. PubMed ID: 30049486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer.
    Liu C; Lou W; Zhu Y; Yang JC; Nadiminty N; Gaikwad NW; Evans CP; Gao AC
    Cancer Res; 2015 Apr; 75(7):1413-22. PubMed ID: 25649766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma.
    Wang X; Wang X; Zhu Z; Li W; Yu G; Jia Z; Wang X
    Biomed Pharmacother; 2019 Sep; 117():109109. PubMed ID: 31229922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exosomal Markers (CD63 and CD9) Expression Pattern Using Immunohistochemistry in Resected Malignant and Nonmalignant Pancreatic Specimens.
    Khushman M; Bhardwaj A; Patel GK; Laurini JA; Roveda K; Tan MC; Patton MC; Singh S; Taylor W; Singh AP
    Pancreas; 2017 Jul; 46(6):782-788. PubMed ID: 28609367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of alphaII(b)beta3 integrin in prostate cancer metastasis.
    Trikha M; Raso E; Cai Y; Fazakas Z; Paku S; Porter AT; Timar J; Honn KV
    Prostate; 1998 May; 35(3):185-92. PubMed ID: 9582087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Small Molecule Inhibits Tumor Growth and Synergizes Effects of Enzalutamide on Prostate Cancer.
    Cheng J; Moore S; Gomez-Galeno J; Lee DH; Okolotowicz KJ; Cashman JR
    J Pharmacol Exp Ther; 2019 Dec; 371(3):703-712. PubMed ID: 31582422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of drug transporter expression by osteopontin in prostate cancer cells.
    Hsieh IS; Huang WH; Liou HC; Chuang WJ; Yang RS; Fu WM
    Mol Pharmacol; 2013 May; 83(5):968-77. PubMed ID: 23434829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Tumor Effects of Exosomes Derived from Drug-Incubated Permanently Growing Human MSC.
    Melzer C; Ohe JV; Hass R
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Exosomes in Prostate Cancer Metastasis.
    Akoto T; Saini S
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protease Cargo in Circulating Exosomes of Breast Cancer and Ovarian Cancer Patients.
    Tamkovich SN; Yunusova NV; Tugutova E; Somov AK; Proskura KV; Kolomiets LA; Stakheeva MN; Grigor’eva AE; Laktionov PP; Kondakova IV
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):255-262. PubMed ID: 30678441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of prostate cancer-related exosomes.
    Mizutani K; Terazawa R; Kameyama K; Kato T; Horie K; Tsuchiya T; Seike K; Ehara H; Fujita Y; Kawakami K; Ito M; Deguchi T
    Anticancer Res; 2014 Jul; 34(7):3419-23. PubMed ID: 24982349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD63 Regulates Epstein-Barr Virus LMP1 Exosomal Packaging, Enhancement of Vesicle Production, and Noncanonical NF-κB Signaling.
    Hurwitz SN; Nkosi D; Conlon MM; York SB; Liu X; Tremblay DC; Meckes DG
    J Virol; 2017 Mar; 91(5):. PubMed ID: 27974566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrin β4 and vinculin contained in exosomes are potential markers for progression of prostate cancer associated with taxane-resistance.
    Kawakami K; Fujita Y; Kato T; Mizutani K; Kameyama K; Tsumoto H; Miura Y; Deguchi T; Ito M
    Int J Oncol; 2015 Jul; 47(1):384-90. PubMed ID: 25997717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular Vesicles in the Adaptive Process of Prostate Cancer during Inhibition of Androgen Receptor Signaling by Enzalutamide.
    Soekmadji C; Rockstroh A; Ramm GA; Nelson CC; Russell PJ
    Proteomics; 2017 Dec; 17(23-24):. PubMed ID: 29105980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular Integrin α5β1 and Exosomal ADAM17 Mediate the Binding and Uptake of Exosomes Produced by Colorectal Carcinoma Cells.
    Cardeñes B; Clares I; Toribio V; Pascual L; López-Martín S; Torres-Gomez A; Sainz de la Cuesta R; Lafuente EM; López-Cabrera M; Yáñez-Mó M; Cabañas C
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can urinary exosomes act as treatment response markers in prostate cancer?
    Mitchell PJ; Welton J; Staffurth J; Court J; Mason MD; Tabi Z; Clayton A
    J Transl Med; 2009 Jan; 7():4. PubMed ID: 19138409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes.
    Hosseini-Beheshti E; Pham S; Adomat H; Li N; Tomlinson Guns ES
    Mol Cell Proteomics; 2012 Oct; 11(10):863-85. PubMed ID: 22723089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients.
    Del Re M; Biasco E; Crucitta S; Derosa L; Rofi E; Orlandini C; Miccoli M; Galli L; Falcone A; Jenster GW; van Schaik RH; Danesi R
    Eur Urol; 2017 Apr; 71(4):680-687. PubMed ID: 27733296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer.
    Su Y; Liu Y; Behrens CR; Bidlingmaier S; Lee NK; Aggarwal R; Sherbenou DW; Burlingame AL; Hann BC; Simko JP; Premasekharan G; Paris PL; Shuman MA; Seo Y; Small EJ; Liu B
    JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.